These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25365428)

  • 81. Adaptations in mitochondrial function parallel, but fail to rescue, the transition to severe hyperglycemia and hyperinsulinemia: a study in Zucker diabetic fatty rats.
    Lenaers E; De Feyter HM; Hoeks J; Schrauwen P; Schaart G; Nabben M; Nicolay K; Prompers JJ; Hesselink MK
    Obesity (Silver Spring); 2010 Jun; 18(6):1100-7. PubMed ID: 19875988
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
    Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pressure pain precedes development of type 2 disease in Zucker rat model of diabetes.
    Romanovsky D; Walker JC; Dobretsov M
    Neurosci Lett; 2008 Nov; 445(3):220-3. PubMed ID: 18790004
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes.
    Takenaka T; Inoue T; Okada H; Ohno Y; Miyazaki T; Chaston DJ; Hill CE; Suzuki H
    Diabetologia; 2011 Aug; 54(8):2192-201. PubMed ID: 21573906
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats.
    Teixeira de Lemos E; Reis F; Baptista S; Pinto R; Sepodes B; Vala H; Rocha-Pereira P; Correia da Silva G; Teixeira N; Silva AS; Carvalho L; Teixeira F; Das UN
    Nutrition; 2009 Mar; 25(3):330-9. PubMed ID: 19062255
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Urine glucose levels are disordered before blood glucose level increase was observed in Zucker diabetic fatty rats.
    Yin W; Qin W; Gao Y
    Sci China Life Sci; 2018 Jul; 61(7):844-848. PubMed ID: 28861867
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Increased metabolic stress in Zucker diabetic fatty rat kidney and pancreas.
    Raza H; John A; Howarth FC
    Cell Physiol Biochem; 2013; 32(6):1610-20. PubMed ID: 24335379
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
    Liu X; Pérusse F; Bukowiecki LJ
    Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Basal insulin hypersecretion in insulin-resistant Zucker diabetic and Zucker fatty rats: role of enhanced fuel metabolism.
    Zhou YP; Cockburn BN; Pugh W; Polonsky KS
    Metabolism; 1999 Jul; 48(7):857-64. PubMed ID: 10421226
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Appropriateness of the Zucker Diabetic Fatty rat as a model for diabetic microvascular late complications.
    Hempe J; Elvert R; Schmidts HL; Kramer W; Herling AW
    Lab Anim; 2012 Jan; 46(1):32-9. PubMed ID: 22087029
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals.
    Wang X; DuBois DC; Sukumaran S; Ayyar V; Jusko WJ; Almon RR
    Diabetes Metab Syndr Obes; 2014; 7():531-41. PubMed ID: 25419150
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression.
    Liu CH; Yang MH; Zhang GZ; Wang XX; Li B; Li M; Woelfer M; Walter M; Wang L
    J Neuroinflammation; 2020 Feb; 17(1):54. PubMed ID: 32050990
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of Isoprenaline on ventricular myocyte shortening and Ca
    Sultan A; Qureshi MA; Howarth FC
    Eur J Pharmacol; 2022 Oct; 933():175263. PubMed ID: 36100128
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Melatonin nephroprotective action in Zucker diabetic fatty rats involves its inhibitory effect on NADPH oxidase.
    Winiarska K; Dzik JM; Labudda M; Focht D; Sierakowski B; Owczarek A; Komorowski L; Bielecki W
    J Pineal Res; 2016 Jan; 60(1):109-17. PubMed ID: 26514550
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Exploring levels of hexosamine biosynthesis pathway intermediates and protein kinase C isoforms in muscle and fat tissue of Zucker Diabetic Fatty rats.
    Bosch RR; Janssen SW; Span PN; Olthaar A; van Emst-de Vries SE; Willems PH; Martens J M G; Hermus AR; Sweep CC
    Endocrine; 2003 Apr; 20(3):247-52. PubMed ID: 12721503
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Defect in glucokinase translocation in Zucker diabetic fatty rats.
    Fujimoto Y; Donahue EP; Shiota M
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E414-23. PubMed ID: 15138155
    [TBL] [Abstract][Full Text] [Related]  

  • 97. HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus.
    Carper MJ; Cade WT; Cam M; Zhang S; Shalev A; Yarasheski KE; Ramanadham S
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E558-67. PubMed ID: 18171911
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats.
    Jöhren O; Dendorfer A; Dominiak P; Raasch W
    Brain Res; 2007 Dec; 1184():160-7. PubMed ID: 17945204
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen.
    Chander PN; Gealekman O; Brodsky SV; Elitok S; Tojo A; Crabtree M; Gross SS; Goligorsky MS
    J Am Soc Nephrol; 2004 Sep; 15(9):2391-403. PubMed ID: 15339988
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
    Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
    J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.